InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Febbo Phillip G., Chief Scientific & Med Officer. Insider active across 2 companies, notably Veracyte, INC.. In total, 23 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €675k. History available since 11 June 2021. The latest transaction was filed on 2 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Febbo Phillip G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
3,730 shares@ US$47.800.0034% mcap12.2% of flowCommon StockSEC:0001649245-26-000007:0
29,603 shares0Common StockSEC:0001649245-26-000006:0
6,035 shares@ US$36.0112.8% of flowCommon StockSEC:0001649245-26-000004:0
71,806 shares0Common StockSEC:0001649245-26-000002:0
2,955 shares@ US$46.169.3% of flowCommon StockSEC:0001649245-25-000007:0
8,349 shares@ US$36.01740.0084% mcap50.0% of flowCommon StockSEC:0001649245-25-000005:0
2,955 shares@ US$30.116.7% of flowCommon StockSEC:0001384101-25-000116:0
2,955 shares@ US$26.746.5% of flowCommon StockSEC:0001384101-25-000068:0
24,160 shares0Common StockSEC:0001384101-25-000044:0
4,467 shares@ US$32.864912.7% of flowCommon StockSEC:0001384101-25-000032:0
30,589 shares0Common StockSEC:0001384101-25-000024:0
3,934 shares@ US$44.089315.0% of flowCommon StockSEC:0001384101-24-000186:0
6,738 shares@ US$44.1225.6% of flowCommon StockSEC:0001384101-24-000179:0
39,904 shares0Common StockSEC:0001384101-24-000036:0
53,182 shares0Common StockSEC:0001384101-23-000155:0
7,556 shares0Common StockSEC:0001127602-23-008575:0
3,522 shares0Common StockSEC:0001127602-23-006823:0
821 shares@ US$217.1923.8% of flowCommon StockSEC:0001127602-22-025123:0
131 shares@ US$363.840.0002% mcap7.5% of flowCommon StockSEC:0001127602-22-011725:0
3,029 shares0Common StockSEC:0001127602-22-008112:0
2,851 shares0Common StockSEC:0001127602-22-006616:0
446 shares@ US$408.140.0007% mcap26.9% of flowCommon StockSEC:0001127602-21-028723:0
310 shares@ US$446.1722.8% of flowCommon StockSEC:0001127602-21-019827:0
23 of 23 declarations
About Febbo Phillip G.
Febbo Phillip G. is Chief Scientific & Med Officer at Veracyte, INC. and SVP Chief Medical Officer at Illumina, INC. He has 23 filings in total, and across the sampled recent filings between 2021-06-14 and 2026-06-04, sell amounts total EUR 675451, with Retenue fiscale as the modal transaction nature.
